글로벌 에페레시스 장비 시장 – 2031년까지의 산업 동향 및 예측

체외채혈 장비 시장 분석 및 규모

글로벌 체외채혈 장비 시장은 앞으로 몇 년 동안 꾸준한 성장을 보일 것으로 예상됩니다. 혈액 질환의 유병률 증가와 혈액 성분에 대한 수요 증가는 체외채혈 장비 수요를 견인하는 주요 요인입니다. 수혈을 필요로 하는 외상 사례와 교통사고의 증가는 시장 성장을 더욱 확대할 것입니다. 또한, 체외채혈이 치료에 중요한 역할을 하는 암과 같은 만성 질환의 증가는 고급 체외채혈 솔루션 판매를 촉진하고 있습니다.

Data Bridge Market Research는 2023년에 37억 달러였던 글로벌 혈액채혈 장비 시장이 2031년까지 86억 5천만 달러에 도달할 것으로 예상되며 2024년에서 2031년까지 예측 기간 동안 11.2%의 CAGR을 기록할 것으로 분석했습니다. "일회용 혈액채혈 키트"는 환자 진단을 위한 더 나은 방법에 대한 수요가 증가함에 따라 시장의 장비 유형 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화

시장 정의

체외채혈 장비는 체외채혈 시술 중 혈액 성분을 자동으로 분리하도록 설계된 의료 기기 를 말합니다 . 체외채혈은 환자의 혈액에서 혈장, 혈소판 또는 백혈구와 같은 특정 성분을 제거하는 동시에 나머지 혈액 성분을 환자의 순환계로 되돌리는 치료 과정입니다. 체외채혈 장비는 일반적으로 밀도나 크기와 같은 물리적 특성에 따라 혈액 성분을 분리할 수 있는 원심분리 또는 여과 시스템이 장착된 기계로 구성됩니다.

체외채혈 장비 시장 동향

운전자

• 기술의 발전

체외채혈 장비의 기술 혁신은 이러한 장치의 효율성, 안전성 및 사용성을 크게 향상시켰습니다. 고급 자동화 기능, 개선된 소프트웨어 알고리즘 및 일회용 키트의 개발로 절차가 간소화되고, 절차 시간이 단축되고, 부작용의 위험이 최소화되었습니다. 예를 들어, 연속 흐름 원심분리 및 소프트웨어 가이드 절차의 도입으로 혈액 성분 분리가 보다 정확하고 효과적으로 이루어졌습니다. 또한 고급 모니터링 시스템과 연결 기능을 통합하여 실시간 데이터 분석 및 원격 모니터링이 가능해져 환자 결과와 운영 효율성이 향상되었습니다. 의료 서비스 제공자가 환자 치료를 최적화하기 위해 최첨단 기술 도입을 점점 더 우선시함에 따라 고급 체외채혈 장비에 대한 수요는 전 세계적으로 계속 증가할 것으로 예상됩니다.

• 만성 질환의 유병률 증가

The increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and cardiovascular diseases is driving the demand for apheresis procedures worldwide. Apheresis therapy plays a crucial role in the management of these conditions by removing harmful substances from the blood, such as excess antibodies, toxins, or cancerous cells. With the growing burden of chronic diseases globally, particularly in aging populations and emerging economies undergoing epidemiological transitions, there is a growing demand for effective therapeutic interventions such as apheresis. Moreover, advancements in precision medicine and personalized therapies have expanded the application of apheresis procedures, creating new opportunities for market growth. As healthcare systems strive to address the rising demand for advanced treatment modalities, the market for apheresis equipment is expected to witness sustained growth in the coming

Opportunities

• Expansion in Emerging Markets

As healthcare infrastructure continues to improve and economies develop in regions such as Asia-Pacific, Latin America, and the Middle East, there is a growing demand for advanced medical technologies, including apheresis equipment. Factors such as increasing prevalence of chronic diseases, rising healthcare expenditure, and expanding access to healthcare services are driving the demand for apheresis procedures in these markets. Companies that strategically expand their presence in emerging markets through partnerships, distribution agreements, or direct investments can tap into this growing demand and capitalize on the untapped market potential to addressing the specific needs and preferences of these markets, manufacturers can establish strong footholds, drive revenue growth, and contribute to improving healthcare outcomes on a global scale.

Restraints/Challenges

• High Initial Investment Costs

Apheresis equipment typically requires a significant upfront investment for procurement, installation, and training. The complex technology and specialized components contribute to high costs, which may deter healthcare facilities from adopting or upgrading their apheresis systems. Additionally, maintenance and servicing expenses can further strain budgets over time. This financial barrier could limit market growth, particularly in regions with limited healthcare budgets or reimbursement constraints. Consequently, healthcare providers may opt for alternative treatment modalities or delay equipment upgrades, impacting market expansion.

• Stringent Regulatory Compliance Requirements

 The global apheresis equipment market is subject to stringent regulatory standards and certification processes imposed by regulatory authorities such as the FDA (Food and Drug Administration) in the United States and the European Medicines Agency (EMA) in Europe. Compliance with these regulations necessitates rigorous testing, documentation, and quality control measures throughout the manufacturing and distribution processes. Failure to meet regulatory requirements can result in product recalls, fines, or delays in market entry, thereby impeding manufacturers' ability to introduce new or upgraded equipment. Moreover, navigating the regulatory landscape incurs additional time and resources, potentially slowing down innovation and product development cycles. As a result, companies operating in the apheresis equipment market must allocate substantial resources to ensure compliance, which may hinder market growth and innovation.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In May 2023, Terumo Corporation a medical device company launched the first training program of its kind to help cell and gene therapy manufacturers improve their cell collection processes and accelerate the commercialization of therapeutics. It will help to trains the participants in apheresis market for the better skills
• In January 2020, Fresenius Kabi AG a pharmaceutical company inaugurated the USD 32.2 Mn expansion of transfusion and apheresis disposables plant in Dominican Republic. This plant expansion will strengthen the company’s role as a major global exporter of apheresis and plasma collection sets

Apheresis Equipment Market Scope

The market is segmented on the basis of equipment type, technology type, procedure type, application, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Equipment Type

• Disposable Apheresis Kits
• Apheresis Machines

Technology Type

• Centrifugation
• Membrane Filtration

 Procedure Type

• Photopheresis
• Plasmapheresis
• LDL Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis,
• Others
  • Lymphopheresis
  •  lipidpheresis

 Application

• Renal Disorders
• , Neurological Disorders
• Hematological Disorders
• Other Disorders

End User

• Hospitals and Clinic
• Ambulatory Surgical Centers
• Blood Donation Centers
• Others

Apheresis Equipment Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided country, Equipment Type, Technology Type, Procedure Type, Application, End User as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.

North America is expected to be the largest market for apheresis equipment market due to a strong presence of leading players in the region. The U.S. is home to many large multinational companies, such as Haemonetics Corporation and Terumo BCT, which have a significant market share in blood component collection and therapeutic apheresis products globally.

Asia Pacific is expected to be the fastest-growing market for apheresis equipment, which is expected to grow at a CAGR of over 10.2% during the forecast period. The growth of the market in Asia Pacific is attributed to the large patient pool, increasing healthcare expenditure, and improving healthcare infrastructure in the region

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The market also provides you with a detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2016-2021.

Competitive Landscape and Apheresis Equipment Market Share Analysis

시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭 및 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• Asahi Kasei Medical Co., Ltd.(일본)
•  Terumo Corporation, Inc. (일본)
• 에인월 주식회사(미국)
• 헤모네틱스 코퍼레이션(미국)
• Therakos, Inc. (미국)
• Braun Melsungen AG(독일)
• 헤마케어 코퍼레이션(미국)
• 헤모네틱스 코퍼레이션(미국)
• 밀테니 바이오텍(독일)
• NxStage Medical(미국)
• 카네카 메딕스 주식회사(일본)

SKU-46707